Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × FED × Nivolumab × Clear all

Phase

Status

Sponsor Class

OTHER 135 INDUSTRY 42 NIH 14 OTHER_GOV 5 NETWORK 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 3 Testosterone 2 Exercise 2 stenoparib 1 enzalutamide 1 capivasertib 1 Waiting Lists 1 Temozolomide 1 Surveys and Questionnaires 1 Radiosurgery 1 Pluvicto 1 PM 01183 1 Nutritional Status 1 Nivolumab 1 Itraconazole 1 Imipramine 1 Focus Groups 1 Dosage Forms 1 Diet 1 Dexmedetomidine 1 Cystoscopy 1 Cognitive Behavioral Therapy 1 Behavior Therapy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06275360 2026-03-02

RIVAL

VA Office of Research and Development

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡